TCL Archive National Academies: Changes Required To Reduce Incidence Of Medical Errors, Report Finds December 3, 1999
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done January 20, 1984
